Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Miliaria profunda

J F Kirk1, B B Wilson, W Chun

  • 1Department of Dermatology, University of Virginia Health Sciences Center, Charlottesville, USA.

Journal of the American Academy of Dermatology
|November 1, 1996
PubMed
Summary
This summary is machine-generated.

Miliaria profunda, a rare and disabling skin condition, can be effectively treated with anhydrous lanolin and isotretinoin. This case study highlights a successful therapeutic approach for this distinctive disorder.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for in-hospital acquisition of carbapenem-resistant Enterobacterales in patients with severe burns.

The Journal of hospital infection·2024
Same author

Net Inflow: An Important Target on the Path to Aquifer Sustainability.

Ground water·2023
Same author

Water Well Hydrographs: An Underutilized Resource for Characterizing Subsurface Conditions.

Ground water·2021
Same author

[Time characteristics of imported malaria cases in Yunnan Province].

Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control·2018
Same author

Image Gallery: Necrobiotic xanthogranuloma in association with chronic myelomonocytic leukaemia.

The British journal of dermatology·2017
Same author

Antibiotic-loaded bone void filler accelerates healing in a femoral condylar rat model.

The bone & joint journal·2016
Same journal

Highlights from JAAD Case Reports: September 2026: Repurposing established therapies through biologic insight.

Journal of the American Academy of Dermatology·2026
Same journal

First-Come, First-Served: Ethics of Coordinated Interview Releases.

Journal of the American Academy of Dermatology·2026
Same journal

Ethical Implications of Integrating Artificial Intelligence Tools into Dermatology Electronic Health Records.

Journal of the American Academy of Dermatology·2026
Same journal

Real-world experience with extended deucravacitinib-biologic combination therapy in refractory psoriasis and psoriatic arthritis.

Journal of the American Academy of Dermatology·2026
Same journal

Acute-phase Disease and Super-responder Status Predict Reduced Relapse Risk After Ritlecitinib Withdrawal in Alopecia Areata: A Prospective Real-World Study.

Journal of the American Academy of Dermatology·2026
Same journal

Response to Kvist-Hansen et al. 'Baseline monocytes ≥925/μL appear to represent a rare outlier phenotype rather than a generalizable predictor of adalimumab response in hidradenitis suppurativa.'

Journal of the American Academy of Dermatology·2026
See all related articles

Area of Science:

  • Dermatology
  • Clinical Medicine

Background:

  • Miliaria profunda is an uncommon but characteristic disorder.
  • It can lead to significant disability for affected individuals.

Observation:

  • A case of miliaria profunda is described.
  • The patient experienced a positive response to treatment.

Findings:

  • Successful therapy involved the use of anhydrous lanolin and isotretinoin.
  • The patient's condition improved with this combined treatment approach.

Implications:

  • This suggests a potential therapeutic strategy for managing miliaria profunda.
  • Further research into the efficacy of anhydrous lanolin and isotretinoin for miliaria profunda is warranted.